The downregulation of CD36 was further confirmed by RT-PCR analysis in that the hepatic gene expression of CD36 was significantly decreased by 36.4% and 29.1% upon Alisol B treatment in DIO+CCl4 and CDA-diet-induced NASH mice, respectively (Figure 3E,G). Here, CD36 is linked to metabolic dysfunction-associated steatohepatitis.